CAGAM Innovative Healthcare Consulting
0669.761.046 · rovalta.com · 28/09/2026
CAGAM Innovative Healthcare Consulting
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOCAGAM Innovative Healthcare Consulting is a Private limited company incorporated in 2017. Its main activity is: Management consultancy activities. Its registered office is in Woluwe-Saint-Pierre.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0669.761.046
- Incorporation
- 19/01/2017
- Legal form
- Private limited company
- Registered office
- Avenue des Cormorans 26
1150 Woluwe-Saint-Pierre · BruxellesSee on map - Contributed capital
- 8 060,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 9 filingsTrend over 9 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -6,2 k € | -111% | 54,8 k € | +381% | 11,4 k € | +116% | -70,6 k € | -134% | -30,1 k € |
| EBITDA | -8,3 k € | -116% | 53,7 k € | +436% | 10 k € | +114% | -72 k € | -133% | -30,9 k € |
| Operating result | -9,1 k € | -117% | 53,2 k € | +489% | 9 k € | +112% | -73 k € | -129% | -31,9 k € |
| Net result | -13,1 k € | -135% | 37,6 k € | +388% | 7,7 k € | +110% | -74,9 k € | -127% | -33 k € |
| Balance sheet | |||||||||
| Equity | 86,7 k € | -13.1% | 99,8 k € | +60.4% | 62,2 k € | -48.6% | 121 k € | -38.2% | 195,9 k € |
| Total assets | 109,4 k € | +1.4% | 107,8 k € | -18.4% | 132,2 k € | -11.3% | 149 k € | -42.5% | 259,3 k € |
| Cash | 36,6 k € | -20.7% | 46,1 k € | -21.0% | 58,4 k € | -30.7% | 84,2 k € | -48.2% | 162,6 k € |
| Debts | 22,7 k € | +181% | 8,1 k € | -88.5% | 70 k € | +150% | 28 k € | -55.8% | 63,4 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Michel Baijot | MandateDirectorendedManagerended |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 15/08/2026 | 27/08/2025 | 02/07/2024 | 27/07/2023 | 02/08/2022 | 31/08/2021 |
| General meeting | 25/06/2026 | 26/06/2025 | 27/06/2024 | 22/06/2023 | 23/06/2022 | 24/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 9 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 25/06/2026 | 15/08/2026 | French | |
| Micro model | 31/12/2024 | 26/06/2025 | 27/08/2025 | French | |
| Micro model | 31/12/2023 | 27/06/2024 | 02/07/2024 | French | |
| Micro model | 31/12/2022 | 22/06/2023 | 27/07/2023 | French | |
| Micro model | 31/12/2021 | 23/06/2022 | 02/08/2022 | French | |
| Micro model | 31/12/2020 | 24/06/2021 | 31/08/2021 | French | |
| Micro model | 31/12/2019 | 25/06/2020 | 10/08/2020 | French | |
| Micro model | 31/12/2018 | 27/06/2019 | 12/08/2019 | French | |
| Micro model | 31/12/2017 | 28/06/2018 | 27/09/2018 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 100 k€ and 250 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Michel Baijot | MandateDirectorendedManagerended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Avenue des Cormorans 26, 1150 Woluwe-Saint-PierreCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00405715 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| CAGAM Innovative Healthcare ConsultingCurrent | accounts 2025 | Accounts 2025 · 2026-00405715 |
| CAGAM SRL | accounts 2021 → 2024 | Accounts 2024 · 2025-00410063 |
Events
- 2025Annual accounts 2025-13,1 k €↓
- 2025Name changeCAGAM Innovative Healthcare Consulting
- 2024Annual accounts 202437,6 k €↑
- 2023Annual accounts 20237,7 k €↑
- 2022Annual accounts 2022-74,9 k €↓
- 2021Annual accounts 2021-33 k €↓
- 2020Annual accounts 202053,8 k €↓
- 2019Annual accounts 2019142,5 k €↑
- 2018Annual accounts 2018-14 k €↓
- 2017Annual accounts 201757,6 k €
- 19/01/2017IncorporationPrivate limited company